Published in Drug Discov Today Dis Models on January 01, 2006
Dengue virus evolution and virulence models. Clin Infect Dis (2007) 1.64
Animal models of dengue virus infection. Viruses (2012) 1.60
Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol (2009) 1.57
Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol (2012) 1.36
Dengue virus-induced hemorrhage in a nonhuman primate model. Blood (2009) 1.29
Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep (2006) 1.24
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol (2013) 0.91
Synchrony of sylvatic dengue isolations: a multi-host, multi-vector SIR model of dengue virus transmission in Senegal. PLoS Negl Trop Dis (2012) 0.91
Cells in dengue virus infection in vivo. Adv Virol (2010) 0.90
Dengue and soluble mediators of the innate immune system. Trop Med Health (2011) 0.87
Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent. Curr Microbiol (2009) 0.86
Issues related to recent dengue vaccine development. Trop Med Health (2011) 0.86
Dengue virus markers of virulence and pathogenicity. Future Virol (2009) 0.83
The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol (2012) 0.83
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome. Virol J (2011) 0.81
Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization. Blood Coagul Fibrinolysis (2010) 0.80
Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy. Am J Trop Med Hyg (2012) 0.80
Computational Identification of Dengue Virus MicroRNA-Like Structures and their Cellular Targets. Bioinform Biol Insights (2014) 0.78
Distinct expression of interferon-induced protein with tetratricopeptide repeats (IFIT) 1/2/3 and other antiviral genes between subsets of dendritic cells induced by dengue virus 2 infection. Immunology (2016) 0.75
Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model. BMC Microbiol (2015) 0.75
Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8+ T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways. PLoS One (2017) 0.75
Event history analysis of dengue fever epidemic and inter-epidemic spells in Barbados, Brazil, and Thailand. Int J Infect Dis (2012) 0.75
Animal models for dengue vaccine development and testing. Clin Exp Vaccine Res (2017) 0.75
PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science (1945) 4.05
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J Virol (2005) 2.44
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis. J Clin Virol (2005) 2.01
SCID mouse models of human stem cell engraftment. Stem Cells (1998) 1.98
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
The future of dengue vaccines. Lancet (2002) 1.90
Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol (2005) 1.78
Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology (2004) 1.61
Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis (1973) 1.55
Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology (2002) 1.55
Development of a novel mouse model for dengue virus infection. Virology (1999) 1.47
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis (2005) 1.43
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am J Trop Med Hyg (1995) 1.31
Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J Gen Virol (2000) 1.30
Recent advances in our knowledge of dengue and sandfly fever. Am J Trop Med Hyg (1955) 1.28
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood (2003) 1.23
NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice. Diabetes (1988) 1.22
Health evaluation of free-ranging and semi-captive orangutans (Pongo pygmaeus pygmaeus) in Sabah, Malaysia. J Wildl Dis (2003) 1.16
Infection of five human liver cell lines by dengue-2 virus. J Med Virol (2000) 1.14
Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells (2005) 1.14
In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods (2004) 1.11
Experimental infection of New World monkeys with dengue and yellow fever viruses. Am J Trop Med Hyg (1958) 1.06
Possible jungle dengue--recent studies and hypotheses. Jpn J Med Sci Biol (1967) 1.03
Immune-deficient mouse models for analysis of human stem cells. Biotechniques (2003) 0.99
Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of Dengue viruses. Am J Epidemiol (1972) 0.95
Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells. J Med Virol (2004) 0.95
Human xenograft models for virus infection. Virology (2000) 0.91
Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J Trop Med Public Health (1997) 0.82
Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus. Contemp Top Lab Anim Sci (2003) 0.82
A novel dengue fever (DF) and dengue haemorrhagic fever (DHF) analysis using artificial neural network (ANN). Comput Methods Programs Biomed (2005) 0.82
Experimental attempts to transmit phlebotomus (sandfly, pappataci) and dengue fevers to chimpanzees. Proc Soc Exp Biol Med (1948) 0.77
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg (2003) 2.16
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14
Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg (2006) 2.07
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol (2009) 1.57
High genetic divergence and recombination in Arenaviruses from the Americas. Virology (2002) 1.37
Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol (2012) 1.36
Report of an NIAID workshop on dengue animal models. Vaccine (2010) 1.23
Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One (2011) 0.99
Variation in vector competence for dengue viruses does not depend on mosquito midgut binding affinity. PLoS Negl Trop Dis (2011) 0.96
Ears of the Armadillo: Global Health Research and Neglected Diseases in Texas. PLoS Negl Trop Dis (2013) 0.95
Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses. J Virol (2010) 0.86
Phylogenetic analysis of the envelope protein (domain III) of dengue 4 viruses. Salud Publica Mex (2002) 0.75